RxDoctor Payments Data

Joanna Harvey

Medical · Mount Pleasant, SCNPI 1316228679

Payments from drug & device makers

$769in general payments, 2019–2025

Across 18 payments — averaging $42.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$134
  • KCI USA, Inc.$128
  • Smith+Nephew$97
  • Genentech USA, Inc.$96
  • AstraZeneca$93
  • Acadia Pharmaceuticals Inc$92
  • plus $130 from 4 others

What the payments were for

  • Food & beverage$769100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$769 in reported general payments places this provider in the 45th percentile of 384 medical providers in South Carolina.

See all medical providers in South Carolina

Medicare billing

Part B allowed, 2024
$67,627
Medicare patients
93
Services billed
748

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
NuplazidPimavanserin Tartrate11$57,899
TrulicityDulaglutide22$22,158
JardianceEmpagliflozin24$7,570
Divalproex Sodium43$3,097
Solifenacin Succinate16$1,672
Quetiapine Fumarate53$1,584
NovologInsulin Aspart13$1,189
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$797
Mirtazapine59$779
Oxycodone Hcl29$726
Atorvastatin Calcium43$701
Omeprazole40$644
Levothyroxine Sodium45$562
Lorazepam43$529
Trazodone Hcl40$443

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Acadia Pharmaceuticals IncNuplazid$92$57,89911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 384 medical providers in South Carolina.

Other medical in Mount Pleasant

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →